G A Storch

Author PubWeight™ 84.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999 3.45
2 Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis 2001 2.16
3 Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 2000 2.13
4 Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol 2005 1.78
5 Enteroviral meningitis in infancy: potential role for polymerase chain reaction in patient management. Pediatrics 1994 1.70
6 An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992 1.69
7 Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J Infect Dis 1998 1.62
8 Cerebrospinal fluid protein concentration in pediatric patients: defining clinically relevant reference values. Arch Pediatr Adolesc Med 2000 1.59
9 Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J 1994 1.53
10 Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 2006 1.52
11 Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients. Bone Marrow Transplant 2006 1.50
12 Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001 1.49
13 Antibiotic-induced lysis of enterococci. J Clin Invest 1981 1.49
14 Bk virus: a clinical review. Clin Infect Dis 2001 1.48
15 BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 2010 1.43
16 Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients. J Clin Microbiol 1992 1.43
17 Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin Infect Dis 1995 1.40
18 Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 1990 1.29
19 Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995 1.28
20 Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997 1.24
21 Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus. J Med Virol 1987 1.23
22 Cytomegalovirus encephalitis. Ann Intern Med 1996 1.21
23 Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR. J Clin Microbiol 1997 1.19
24 Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993 1.16
25 Evaluation of a genetically engineered cell line and a histochemical beta-galactosidase assay to detect herpes simplex virus in clinical specimens. J Clin Microbiol 1993 1.14
26 Granulomatous hepatitis associated with cat scratch disease. Lancet 1988 1.12
27 Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol 1995 1.10
28 Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am J Med 1998 1.09
29 Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens. J Clin Microbiol 1999 1.09
30 Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests. J Infect Dis 1984 1.08
31 Preparation of urine samples for use in commercial latex agglutination tests for bacterial antigens. J Clin Microbiol 1985 1.07
32 Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1995 1.07
33 Comparison of the Oxoid Signal blood culture system with supplemented peptone broth in a pediatric hospital. J Clin Microbiol 1989 1.07
34 Methicillin-resistant Staphylococcus aureus bacteremia in children. Pediatr Infect Dis 1986 1.06
35 Comparison of automated Difco ESP blood culture system with biphasic BBL Septi-Chek system for detection of bloodstream infections in pediatric patients. J Clin Microbiol 1995 1.04
36 Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 2001 1.03
37 PCR amplification and phylogenetic analysis of groESL operon sequences from Ehrlichia ewingii and Ehrlichia muris. J Clin Microbiol 2000 1.02
38 Optimizing recovery of cytomegalovirus in the shell vial culture procedure. Diagn Microbiol Infect Dis 1991 1.01
39 The epidemiology of influenza B in a rural setting in 1977. Am J Epidemiol 1979 1.00
40 Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr 1995 0.99
41 Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. J Am Soc Nephrol 1997 0.98
42 Use of polymerase chain reaction to demonstrate cytomegalovirus DNA in CSF of patients with human immunodeficiency virus infection. Neurology 1993 0.97
43 Methicillin-resistant Staphylococcus aureus in a nursing home. Infect Control 1987 0.96
44 Evolution of sequence divergence among human immunodeficiency virus type 1 isolates derived from a blood donor and a recipient. Pediatr Res 1993 0.96
45 Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus. Virus Res 1999 0.96
46 Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis. J Clin Microbiol 1997 0.95
47 Evaluation of a commercial DNA enzyme immunoassay for detection of enterovirus reverse transcription-PCR products amplified from cerebrospinal fluid specimens. J Clin Microbiol 2000 0.95
48 Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay. J Clin Microbiol 2001 0.95
49 Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation 1997 0.95
50 Polymerase chain reaction for Streptococcus pyogenes used to evaluate an optical immunoassay for the detection of group A streptococci in children with pharyngitis. Pediatr Infect Dis J 1997 0.91
51 Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis 1992 0.91
52 Comparison of the Bactec Peds Plus pediatric blood culture vial with Roche pediatric Septi-Chek for blood cultures from pediatric patients. J Clin Microbiol 1992 0.91
53 Multiple recurrent branch retinal artery occlusions associated with varicella zoster virus. Retina 1996 0.90
54 Comparison of the BacT/Alert FAN aerobic and the Difco ESP 80A aerobic bottles for pediatric blood cultures. J Clin Microbiol 1997 0.87
55 Comparison of methods for serotyping isolates of Haemophilus influenzae. J Clin Microbiol 1985 0.86
56 Evaluation of new commercial enzyme immunoassay for rotavirus detection. J Clin Microbiol 1987 0.86
57 Vaccinia keratouveitis manifesting as a masquerade syndrome. Am J Ophthalmol 1994 0.85
58 The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation. Transplantation 1999 0.85
59 Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology 1997 0.84
60 Direct quantitative comparison of shell vial and conventional culture for detection of CMV viremia. Clin Diagn Virol 1995 0.84
61 Comparative laboratory diagnosis of experimental herpes simplex keratitis. Am J Ophthalmol 1990 0.83
62 Herpes simplex meningitis in infancy. Pediatr Infect Dis J 1994 0.82
63 Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. J Infect Dis 1995 0.82
64 The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. Bone Marrow Transplant 2007 0.82
65 Evaluation of the pediatric Septi-Chek blood culture system. Diagn Microbiol Infect Dis 1992 0.81
66 Characterization of prolonged apneic episodes associated with respiratory syncytial virus infection. Pediatr Pulmonol 1989 0.80
67 Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neurovirol 1996 0.79
68 Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants. Am J Med 1993 0.79
69 Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students. J Infect Dis 1984 0.78
70 MR imaging of herpes simplex type 1 encephalitis in infants and young children: a separate pattern of findings. AJR Am J Roentgenol 2000 0.78
71 The chest roentgenogram in sporadic cases of Legionnaires' disease. JAMA 1981 0.78
72 Clinical outcomes of solid organ transplant recipients with ehrlichiosis. Transpl Infect Dis 2009 0.77
73 Ganciclovir for cytomegalovirus after heart transplantation. N Engl J Med 1992 0.77
74 Shigellosis in the Marshall Islands: epidemiologic aspects of an outbreak. Am J Trop Med Hyg 1980 0.76
75 Use of conventional and IgM-specific radioimmunoassays for anti-hepatitis A antibody in an outbreak of hepatitis A. Am J Med 1982 0.76
76 Presumed parvovirus B19-associated retinal pigment epitheliopathy. Retina 2000 0.75
77 Control of a rubella outbreak in a dental school population. J Am Dent Assoc 1984 0.75
78 Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis. Am J Kidney Dis 1993 0.75
79 The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis 2000 0.75
80 Prevalence of hepatitis B antibodies in personnel at a children's hospital. Pediatrics 1985 0.75
81 Preemptive ganciclovir therapy in renal transplantation. Ann Intern Med 1996 0.75
82 Laboratory diagnosis of HIV infection. Mo Med 1989 0.75
83 Pediatric meningococcal conjunctivitis. J Pediatr Ophthalmol Strabismus 1999 0.75
84 A rubella outbreak among dental students: description of the outbreak and analysis of control measures. Infect Control 1985 0.75
85 Polymerase chain reaction-triggered preemptive or deferred therapy to control cytomegalovirus-associated morbidity and costs in renal transplant patients. Transplant Proc 1997 0.75
86 Clinical conferences in critical care: Legionnaires' disease. Heart Lung 1982 0.75